Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plc | President, Orexin Program | Ordinary Shares | 208K | $3.56M | $17.17 | Aug 1, 2025 | Direct |
Centessa Pharmaceuticals plc | President, Orexin Program | Share Option (right to buy) | 35K | Sep 9, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNTA | Centessa Pharmaceuticals plc | Sep 16, 2025 | 2 | -$175K | 4 | Sep 16, 2025 | President, Orexin Program |
CNTA | Centessa Pharmaceuticals plc | Sep 9, 2025 | 3 | -$100K | 4 | Sep 11, 2025 | President, Orexin Program |
CNTA | Centessa Pharmaceuticals plc | Aug 1, 2025 | 1 | -$10.3K | 4 | Aug 1, 2025 | President, Orexin Program |
CNTA | Centessa Pharmaceuticals plc | Jul 29, 2025 | 1 | -$127K | 4 | Jul 30, 2025 | President, Orexin Program |
CNTA | Centessa Pharmaceuticals plc | Jun 24, 2025 | 3 | -$152K | 4 | Jun 25, 2025 | President, Orexin Program |
CNTA | Centessa Pharmaceuticals plc | Jun 13, 2025 | 0 | $0 | 3 | Jun 24, 2025 | President, Orexin Program |